How biotech innovation can be harnessed
The COVID-19 pandemic has reshaped attitudes toward public health, fiscal policy and the state’s role in the economy. Demands for greater supply chain resilience and strategic autonomy in developing and producing medicines have given rise to the concept of “life science sovereignty.” For example, French President Emmanuel Macron has announced an ambitious plan calling for